07:00 , Aug 28, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Cardiomyopathy; heart failure Hydroxyeicosapentaenoic acid (18-HEPE) Mouse studies suggest the eicosapentaenoic acid metabolite 18-HEPE could be...